Australia markets closed

Valens Semiconductor Ltd. (VLN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
2.36000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 248.30M
Enterprise value 108.23M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.86
Price/book (mrq)1.51
Enterprise value/revenue 1.29
Enterprise value/EBITDA -4.28

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3-6.72%
S&P500 52-week change 323.57%
52-week high 32.7780
52-week low 31.9100
50-day moving average 32.2926
200-day moving average 32.3632

Share statistics

Avg vol (3-month) 3320.41k
Avg vol (10-day) 3401.64k
Shares outstanding 5105.21M
Implied shares outstanding 6105.21M
Float 867.63M
% held by insiders 110.12%
% held by institutions 139.30%
Shares short (15 Apr 2024) 4175.59k
Short ratio (15 Apr 2024) 40.57
Short % of float (15 Apr 2024) 40.23%
Short % of shares outstanding (15 Apr 2024) 40.17%
Shares short (prior month 15 Mar 2024) 4196.4k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -23.36%
Operating margin (ttm)-7.91%

Management effectiveness

Return on assets (ttm)-8.94%
Return on equity (ttm)-11.85%

Income statement

Revenue (ttm)84.16M
Revenue per share (ttm)0.82
Quarterly revenue growth (yoy)-6.50%
Gross profit (ttm)N/A
EBITDA -25.29M
Net income avi to common (ttm)-19.66M
Diluted EPS (ttm)-0.1900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)142.02M
Total cash per share (mrq)1.35
Total debt (mrq)1.96M
Total debt/equity (mrq)1.19%
Current ratio (mrq)10.97
Book value per share (mrq)1.59

Cash flow statement

Operating cash flow (ttm)-6.36M
Levered free cash flow (ttm)-2.71M